United States · Bill · S
S. 1437 (116th)
Drug-price Transparency in Communications (DTC) Act
Introduced
13 May 2019
Last action
—
Status
Read twice and referred to the Committee on Finance. (text: CR S2791)
Sponsors
—
Subjects
Discovery layer
Source updated
7 April 2025
Summary
Drug-price Transparency in Communications (DTC) Act This bill provides statutory authority for the Centers for Medicare & Medicaid Services rule titled Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency , published on May 10, 2019. The rule requires direct-to-consumer television advertisements for covered drugs and biologics under Medicare and Medicaid to include the list price of a 30-day supply or for a typical course of treatment, if the list price is at least $35 per month. The rule takes effect July 9, 2019.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 13 May 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 13 May 2019
Introduced in Senate
summary · EN · 13 May 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/1437
- Open data entity: https://api.congress.gov/v3/bill/116/s/1437